Altamira Therapeutics Ltd
NASDAQ:CYTO

Watchlist Manager
Altamira Therapeutics Ltd Logo
Altamira Therapeutics Ltd
NASDAQ:CYTO
Watchlist
Price: 0.1198 USD -60.07% Market Closed
Market Cap: 300k USD

Wall Street
Price Targets

CYTO Price Targets Summary
Altamira Therapeutics Ltd

There are no price targets for CYTO.
Lowest
Price Target
Not Available
Average
Price Target
Not Available
Highest
Price Target
Not Available
Altamira Therapeutics Ltd Competitors:
Price Targets
1789
ScinoPharm Taiwan Ltd
8% Downside
688176
Jiangsu Yahong Meditech Co Ltd
18% Downside
4528
Ono Pharmaceutical Co Ltd
21% Downside
AGY
Allergy Therapeutics PLC
11% Upside
TRUL
Trulieve Cannabis Corp
63% Upside
4015
Jamjoom Pharmaceuticals Factory Company SJSC
14% Upside
SUNPHARMA
Sun Pharmaceutical Industries Ltd
14% Upside
4519
Chugai Pharmaceutical Co Ltd
7% Upside

Revenue
Forecast

Revenue Estimate
Altamira Therapeutics Ltd

The compound annual growth rate of Altamira Therapeutics Ltd's revenue for the next 3 years is 214%.

N/A
Past Growth
214%
Estimated Growth
N/A
Estimates Accuracy
N/A
Average

Operating Income
Forecast

Operating Income Estimate
Altamira Therapeutics Ltd

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-10%
Average Miss

Net Income
Forecast

Net Income Estimate
Altamira Therapeutics Ltd

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-100%
Average Miss
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is CYTO's stock price target?
Not Available

CYTO doesn't have any price targets made by Wall Street professionals.

What is Altamira Therapeutics Ltd's Revenue forecast?
Projected CAGR
214%

The compound annual growth rate of Altamira Therapeutics Ltd's revenue for the next 3 years is 214%.

Back to Top